To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Apr. 09 2024

Source Page: MHRA FOI performance data
Document: (Excel)

Found: 113Post-Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus

Departmental Publication (News and Communications)
Department for Levelling Up, Housing & Communities

Mar. 22 2024

Source Page: Recovered appeals: land south of Chiswell Green Lane and land north of Chiswell Green Lane, St. Albans (refs: 3313110 and 3312277 - 22 March 2024)
Document: Recovered appeals: land south of Chiswell Green Lane and land north of Chiswell Green Lane, St. Albans (refs: 3313110 and 3312277 - 22 March 2024) (PDF)

Found: Housing Delivery Test (“HDT”) since 2016/17, even when the targets we re artificially reduced due to Coronavirus

Select Committee
Large Print - Accessibility of products and services to disabled people

Report Mar. 19 2024

Committee: Women and Equalities Committee

Found: vision, motor difficulties, cognitive impairments or learning disabilities, and deafness or impaired hearing

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 1 (PDF)

Found: COVID -19 Coronavirus Disease 2019 .

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/879 - attachment 2 (PDF)

Found: External ear disorders NEC Auricular swelling 1 0 Excessive cerumen production 1 0 Hearing

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/857 - attachment 5 (PDF)

Found: NEC Ear discomfort 1 0 Eustachian tube disorders Eustachian tube obstruction 1 0 Hearing

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 2 (PDF)

Found: However, the events acute macular outer retinopathy and visual impairment could be related.

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/937 - attachment 2 (PDF)

Found: External ear disorders NEC Auricular swelling 1 0 Excessive cerumen production 1 0 Hearing

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/908 - attachment 3 (PDF)

Found: solution for injection COVID -19 Vaccine (ChAdOx1 S [recombinant]) Therapeutic area: Prevention of coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 27 November 2023
Document: FOI 23/858 - attachment (PDF)

Found: in side -effects/adverse effects that may include cochlear hair cell damage in the ear, tinnitus, hearing